Both in Pharmaceuticals
Zevra Therapeutics vs Immix Biopharma
Over the past year ZVRA returned +6.6% and IMMX returned +114.0%; their daily moves had a correlation of 0.27.
ZVRA +6.6% IMMX +114.0%Growth of $1, one year, split-adjusted
| Metric | ZVRA | IMMX |
|---|---|---|
| Price | $10.88 | $7.79 |
| Market cap | $646.1M | $645.8M |
| Today | +6.04% | +1.04% |
| 1 month | +1.4% | −19.2% |
| 6 months | −3.3% | −24.5% |
| Year to date | +21.4% | +48.9% |
| 1 year | +6.6% | +114.0% |
| Revenue growth (YoY) | +44.9% | — |
| Gross margin | 95.2% | — |
| Net margin | 48.8% | — |
| P/E (TTM) | 8.4× | — |
| Price / sales | 4.4× | — |
| Net cash | $188.3M | $232.1M |
| Dividend yield | — | — |
| Volatility (60d) | 45.9% | 64.0% |
| Short % of float | 10.8% | 22.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).